Unique ID issued by UMIN | UMIN000040699 |
---|---|
Receipt number | R000046450 |
Scientific Title | Internet-based cognitive behavioral therapy for patients with obsessive-compulsive disorder: A rescue trial |
Date of disclosure of the study information | 2020/06/10 |
Last modified on | 2021/12/10 16:19:23 |
Effectiveness of Web-based cognitive behavioral therapy program for patients with obsessive-compulsive disorder: A rescue trial
A rescue trial of web based-cognitive behavioral therapy for obsessive-compulsive disorder
Internet-based cognitive behavioral therapy for patients with obsessive-compulsive disorder: A rescue trial
A rescue trial of Internet-based cognitive behavioral therapy for obsessive-compulsive disorder
Japan |
Obsessive-compulsive disorder
Psychosomatic Internal Medicine | Psychiatry |
Others
NO
The objective is to treat patients with obsessive-compulsive disorder assigned to the waiting group in the preceding randomized controlled trial.
Safety,Efficacy
Confirmatory
Explanatory
Phase II
Assessments of severity by using Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) will be performed at baseline and at the end of the intervention (12 weeks after the beginning of the intervention).
Obsessive-Compulsive Inventory, Working Alliance Inventory-Short From, EuroQol 5 Divison, Patient Health Questionnaire-9, Generalized Anxiety Disorder -7 at baseline and at the end of the intervention (12 weeks after the beginning of the intervention).
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Behavior,custom |
Self-help based on cognitive behavioral science. Patients are going to conduct self-help by using e-learning with minimal guidance by a cognitive behavioral therapist, at once a week for 12 consecutive weeks. The treatment module includes psychoeducation, case conceptualization, behavioral experiment, cognitive reconstruction, creation of anxiety hierarchy vote, exposure response obstruction method, and recurrence prevention.
15 | years-old | <= |
60 | years-old | >= |
Male and Female
Inclusion criteria:
1) Patients meets the diagnostic criteria for obsessive-compulsive disorder by the Mini-International Neuropsychiatric Interview (M.I.N.I.) meets with a total Y-BOCS score of 14 or more;
2) Those who have completed the 12-week waiting period in the previous randamized controlled trial (Study No. G2019017);
3) The age at the time of obtaining consent is between 15 and 60;
4) A person who intends to participate voluntarily and agrees to the research content after explaining the research content;
5) Ordinary treatment is given, and no new initiation or additional modification of drug therapy is planned during the study period;
6) Personal computer, tablet, smartphone, or other computer device capable of communication, or the guardian of a subject who is less than an adult owns the above device, and the subject himself or herself substantially uses it on a daily basis;
7) Have an Internet communication environment and have skills (send mail, open files, receive mail and read);
8) Has not received any cognitive-behavioral therapy, including exposure-response interference, for the last 2 years.
Exclusion criteria:
1) Organic disorders of the brain (including dementia), psychotic disorders, bipolar disorders, serious psychiatric disorders such as drug dependence, etc. are complicated, and cognitive-behavioral therapy is expected to be interrupted due to deterioration of these symptoms;
2) The cognitive-behavioral therapy is expected to be interrupted due to the imminent risk of suicide;
3) Cognitive behavioral therapy is expected to be interrupted due to repeated antisocial behavior;
4) Cognitive-behavioral therapy is expected to be discontinued due to severe progressive physical illness;
5) Due to severe stress reaction and dissociation symptoms due to acute stress disorder and post-traumatic stress disorder, it is difficult to expose to feared subjects;
6) There are significant problems due to attention deficit and hyperactivity disorderand autism spectrum disorder, and it is predicted that it will be difficult to receive stable treatment in the study conducted in this clinical study;
7) Those who reject the ERP;
8) Any other person who is judged by the investigator or the therapist to be unsuitable for the safe conduct of this study.
15
1st name | Eiji |
Middle name | |
Last name | Shimizu |
Graduate School of Medicine at Chiba University
Department of Cognitive Behavioral Physiology
2608670
1-8-1, Inohana, Chuo-ku Chiba, 2608670 Japan
043-226-2027
neurophys1@ML.chiba-u.jp
1st name | Kazuki |
Middle name | |
Last name | Matsumoto |
Chiba University
Research Center for Child Mental Development
2608679
1-8-1, Inohana, Chuo-ku Chiba, 2608670 Japan
043-226-2975
axpa0219@chiba-u.jp
Research Center for Child Metnal Development, Chiba University
Japan society for the promotion of science
Japanese Governmental office
Chiba University Hospital
1-8-1, Inohana, Chuo-ku Chiba, 2608670 Japan
043-222-7171
ayamazaki@ office.chiba-u.jp
NO
千葉大学医学部附属病院(千葉県)、福井大学医学部附属病院(福井県)
2020 | Year | 06 | Month | 10 | Day |
Unpublished
12
Completed
2020 | Year | 02 | Month | 22 | Day |
2020 | Year | 04 | Month | 01 | Day |
2020 | Year | 06 | Month | 17 | Day |
2021 | Year | 06 | Month | 30 | Day |
2020 | Year | 06 | Month | 09 | Day |
2021 | Year | 12 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046450